47 related articles for article (PubMed ID: 36422798)
21. Ivermectin Augments the In Vitro and In Vivo Efficacy of Cisplatin in Epithelial Ovarian Cancer by Suppressing Akt/mTOR Signaling.
Zhang X; Qin T; Zhu Z; Hong F; Xu Y; Zhang X; Xu X; Ma A
Am J Med Sci; 2020 Feb; 359(2):123-129. PubMed ID: 32039764
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-20a-5p inhibits epithelial to mesenchymal transition and invasion of endometrial cancer cells by targeting STAT3.
Huang Y; Yang N
Int J Clin Exp Pathol; 2018; 11(12):5715-5724. PubMed ID: 31949657
[TBL] [Abstract][Full Text] [Related]
23. m
Liu L; Wang J; Sun G; Wu Q; Ma J; Zhang X; Huang N; Bian Z; Gu S; Xu M; Yin M; Sun F; Pan Q
Mol Cancer; 2019 Dec; 18(1):188. PubMed ID: 31870368
[TBL] [Abstract][Full Text] [Related]
24. Combination of the natural compound Periplocin and TRAIL induce esophageal squamous cell carcinoma apoptosis in vitro and in vivo: Implication in anticancer therapy.
Han L; Dai S; Li Z; Zhang C; Wei S; Zhao R; Zhang H; Zhao L; Shan B
J Exp Clin Cancer Res; 2019 Dec; 38(1):501. PubMed ID: 31864387
[TBL] [Abstract][Full Text] [Related]
25. LncRNA HCG11 accelerates the progression of hepatocellular carcinoma via miR-26a-5p/ATG12 axis.
Li ML; Zhang Y; Ma LT
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10708-10720. PubMed ID: 31858580
[TBL] [Abstract][Full Text] [Related]
26. Targeted activation of Stat3 in combination with paclitaxel results in increased apoptosis in epithelial ovarian cancer cells and a reduced tumour burden.
Li H; Qian Y; Wang X; Pi R; Zhao X; Wei X
Cell Prolif; 2020 Jan; 53(1):e12719. PubMed ID: 31778258
[TBL] [Abstract][Full Text] [Related]
27. Achieving gastroresistance without coating: Formulation of capsule shells from enteric polymers.
Barbosa JAC; Al-Kauraishi MM; Smith AM; Conway BR; Merchant HA
Eur J Pharm Biopharm; 2019 Nov; 144():174-179. PubMed ID: 31541663
[TBL] [Abstract][Full Text] [Related]
28. Human Papilloma Virus-Associated Cervical Cancer and Health Disparities.
Olusola P; Banerjee HN; Philley JV; Dasgupta S
Cells; 2019 Jun; 8(6):. PubMed ID: 31234354
[TBL] [Abstract][Full Text] [Related]
29. Napabucasin (BBI608) eliminate AML cells in vitro and in vivo via inhibition of Stat3 pathway and induction of DNA damage.
Bi S; Chen K; Feng L; Fu G; Yang Q; Deng M; Zhao H; Li Z; Yu L; Fang Z; Xu B
Eur J Pharmacol; 2019 Jul; 855():252-261. PubMed ID: 31085238
[TBL] [Abstract][Full Text] [Related]
30. Population pharmacokinetics of oral ivermectin in venous plasma and dried blood spots in healthy volunteers.
Duthaler U; Suenderhauf C; Karlsson MO; Hussner J; Meyer Zu Schwabedissen H; Krähenbühl S; Hammann F
Br J Clin Pharmacol; 2019 Mar; 85(3):626-633. PubMed ID: 30566757
[TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetic determinants of cisplatin-induced subclinical kidney injury in oncology patients.
Ibrahim ME; Chang C; Hu Y; Hogan SL; Mercke N; Gomez M; O'Bryant CL; Bowles DW; George B; Wen X; Buckley B; Aleksunes L; Joy MS
Eur J Clin Pharmacol; 2019 Jan; 75(1):51-57. PubMed ID: 30220072
[TBL] [Abstract][Full Text] [Related]
32. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Bray F; Ferlay J; Soerjomataram I; Siegel RL; Torre LA; Jemal A
CA Cancer J Clin; 2018 Nov; 68(6):394-424. PubMed ID: 30207593
[TBL] [Abstract][Full Text] [Related]
33. STAT3 inhibition induces Bax-dependent apoptosis in liver tumor myeloid-derived suppressor cells.
Guha P; Gardell J; Darpolor J; Cunetta M; Lima M; Miller G; Espat NJ; Junghans RP; Katz SC
Oncogene; 2019 Jan; 38(4):533-548. PubMed ID: 30158673
[TBL] [Abstract][Full Text] [Related]
34. JAK/STAT3-Regulated Fatty Acid β-Oxidation Is Critical for Breast Cancer Stem Cell Self-Renewal and Chemoresistance.
Wang T; Fahrmann JF; Lee H; Li YJ; Tripathi SC; Yue C; Zhang C; Lifshitz V; Song J; Yuan Y; Somlo G; Jandial R; Ann D; Hanash S; Jove R; Yu H
Cell Metab; 2018 Jun; 27(6):1357. PubMed ID: 29874570
[No Abstract] [Full Text] [Related]
35. MicroRNA expression in cervical cancer: Novel diagnostic and prognostic biomarkers.
Gao C; Zhou C; Zhuang J; Liu L; Liu C; Li H; Liu G; Wei J; Sun C
J Cell Biochem; 2018 Aug; 119(8):7080-7090. PubMed ID: 29737570
[TBL] [Abstract][Full Text] [Related]
36. BBI608 inhibits cancer stemness and reverses cisplatin resistance in NSCLC.
MacDonagh L; Gray SG; Breen E; Cuffe S; Finn SP; O'Byrne KJ; Barr MP
Cancer Lett; 2018 Aug; 428():117-126. PubMed ID: 29653268
[TBL] [Abstract][Full Text] [Related]
37. MiR-155-5p inhibits PDK1 and promotes autophagy via the mTOR pathway in cervical cancer.
Wang F; Shan S; Huo Y; Xie Z; Fang Y; Qi Z; Chen F; Li Y; Sun B
Int J Biochem Cell Biol; 2018 Jun; 99():91-99. PubMed ID: 29627439
[TBL] [Abstract][Full Text] [Related]
38. Design, synthesis and activity of BBI608 derivatives targeting on stem cells.
Zhou Q; Peng C; Du F; Zhou L; Shi Y; Du Y; Liu D; Sun W; Zhang M; Chen G
Eur J Med Chem; 2018 May; 151():39-50. PubMed ID: 29604543
[TBL] [Abstract][Full Text] [Related]
39. Island.
Burki TK
Lancet Oncol; 2017 Dec; 18(12):1578. PubMed ID: 29413754
[No Abstract] [Full Text] [Related]
40. Clinical Pharmacokinetics of Paclitaxel Monotherapy: An Updated Literature Review.
Stage TB; Bergmann TK; Kroetz DL
Clin Pharmacokinet; 2018 Jan; 57(1):7-19. PubMed ID: 28612269
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]